Kevin A. Hay
- Oncology top 0.5%
- Genetics top 2%
- Biomedical Engineering top 5%
- Immunology top 5%
- Molecular Biology top 10%
- Co-authors
- Cameron J. TurtleDavid G. MaloneyStanley R. RiddellDaniel LiLaïla‐Aïcha HanafiXueyan ChenSindhu CherianSusanna Harju-Baker
- Topics
- CAR-T cell therapy research (29 papers)Lymphoma Diagnosis and Treatment (9 papers)Chronic Lymphocytic Leukemia Research (7 papers)
- Cited by
- OncologyGeneticsImmunology
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
Kevin A. Hay
41 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Oncology 3.2k
- Genetics 883
- Biomedical Engineering 874
- Immunology 770
- Molecular Biology 761
Countries citing papers authored by Kevin A. Hay
This map shows the geographic impact of Kevin A. Hay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin A. Hay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin A. Hay more than expected).
Fields of papers citing papers by Kevin A. Hay
This network shows the impact of papers produced by Kevin A. Hay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin A. Hay. The network helps show where Kevin A. Hay may publish in the future.
Co-authorship network of co-authors of Kevin A. Hay
This figure shows the co-authorship network connecting the top 25 collaborators of Kevin A. Hay. A scholar is included among the top collaborators of Kevin A. Hay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin A. Hay. Kevin A. Hay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 18 | |
| 5 | 3 | |
| 6 | 0 | |
| 7 | 3 | |
| 8 | 12 | |
| 9 | 65 | |
| 10 | 28 | |
| 11 | 18 | |
| 12 | 130 | |
| 13 | 121 | |
| 14 | 2 | |
| 15 | Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cellsbreakdown → | 948 |
| 16 | 97 | |
| 17 | 8 | |
| 18 | 16 | |
| 19 | Portable head computed tomography for rural centres. | 1 |
| 20 | 84 |
About Kevin A. Hay
Kevin A. Hay is a scholar working on Oncology, Genetics and Hematology, having authored 42 papers that have together received 3.9k indexed citations. Recurring topics across this work include CAR-T cell therapy research (29 papers), Lymphoma Diagnosis and Treatment (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). The work is most often cited by research in Oncology (3.2k citations), Genetics (419 citations) and Immunology (770 citations). Kevin A. Hay has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Cameron J. Turtle, David G. Maloney, Stanley R. Riddell, Daniel Li, Laïla‐Aïcha Hanafi, Xueyan Chen, Sindhu Cherian, Susanna Harju-Baker, Juliane Gust and Dominic W. Chung. Their work appears in journals such as Journal of Clinical Oncology, Blood and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.